Product

BIIB017

Aliases

BIIB017 (peginterferon beta-1a), PLEGRIDY

1 clinical trial

2 indications

Indication

Multiple Sclerosis

Indication

Relapsing-Remitting

Clinical trial

An Open-Label, Randomized, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 in Pediatric Subjects Aged 10 to Less Than 18 Years for the Treatment of Relapsing-Remitting Multiple Sclerosis, With Optional Open-Label Extension

Status: Recruiting, Estimated PCD: 2029-11-05